Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 05/15/14
Due: 05/15/15
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 01/31/13
Due: 01/31/14
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 12/31/15
Due: 12/31/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer | NCT00723125 | William Sikov MD | user2@example.com | None | 2008-09-30 | 2014-05-15 | 2015-05-15 | - | - | 2025-07-14 |
| Complete Neoadjuvant Treatment for REctal Cancer (CONTRE) | NCT01363843 | William Sikov MD | user2@example.com | None | 2010-05-31 | 2013-01-31 | 2014-01-31 | - | - | 2025-07-14 |
| Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer | NCT00617942 | William Sikov MD | user2@example.com | None | 2008-02-29 | 2015-12-31 | 2016-12-31 | - | - | 2025-07-14 |